Effect of oral sebacic Acid on postprandial glycemia, insulinemia, and glucose rate of appearance in type 2 diabetes. 2010

Amerigo Iaconelli, and Amalia Gastaldelli, and Chiara Chiellini, and Donatella Gniuli, and Angela Favuzzi, and Christophe Binnert, and Katherine Macé, and Geltrude Mingrone
Department of Internal Medicine, Catholic University of Rome, Rome, Italy.

OBJECTIVE Dicarboxylic acids are natural products with the potential of being an alternate dietary source of energy. We aimed to evaluate the effect of sebacic acid (a 10-carbon dicarboxylic acid; C10) ingestion on postprandial glycemia and glucose rate of appearance (Ra) in healthy and type 2 diabetic subjects. Furthermore, the effect of C10 on insulin-mediated glucose uptake and on GLUT4 expression was assessed in L6 muscle cells in vitro. METHODS Subjects ingested a mixed meal (50% carbohydrates, 15% proteins, and 35% lipids) containing 0 g (control) or 10 g C10 in addition to the meal or 23 g C10 as a substitute of fats. RESULTS In type 2 diabetic subjects, the incremental glucose area under the curve (AUC) decreased by 42% (P<0.05) and 70% (P<0.05) in the 10 g C10 and 23 g C10 groups, respectively. At the largest amounts used, C10 reduced the glucose AUC in healthy volunteers also. When fats were substituted with 23 g C10, AUC of Ra was significantly reduced on the order of 18% (P<0.05) in both healthy and diabetic subjects. The insulin-dependent glucose uptake by L6 cells was increased in the presence of C10 (38.7±10.3 vs. 11.4±5.4%; P=0.026). This increase was associated with a 1.7-fold raise of GLUT4. CONCLUSIONS Sebacic acid significantly reduced hyperglycemia after a meal in type 2 diabetic subjects. This beneficial effect was associated with a reduction in glucose Ra, probably due to lowered hepatic glucose output and increased peripheral glucose disposal.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D008401 Gas Chromatography-Mass Spectrometry A microanalytical technique combining mass spectrometry and gas chromatography for the qualitative as well as quantitative determinations of compounds. Chromatography, Gas-Liquid-Mass Spectrometry,Chromatography, Gas-Mass Spectrometry,GCMS,Spectrometry, Mass-Gas Chromatography,Spectrum Analysis, Mass-Gas Chromatography,Gas-Liquid Chromatography-Mass Spectrometry,Mass Spectrometry-Gas Chromatography,Chromatography, Gas Liquid Mass Spectrometry,Chromatography, Gas Mass Spectrometry,Chromatography, Mass Spectrometry-Gas,Chromatography-Mass Spectrometry, Gas,Chromatography-Mass Spectrometry, Gas-Liquid,Gas Chromatography Mass Spectrometry,Gas Liquid Chromatography Mass Spectrometry,Mass Spectrometry Gas Chromatography,Spectrometries, Mass-Gas Chromatography,Spectrometry, Gas Chromatography-Mass,Spectrometry, Gas-Liquid Chromatography-Mass,Spectrometry, Mass Gas Chromatography,Spectrometry-Gas Chromatography, Mass,Spectrum Analysis, Mass Gas Chromatography
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D001823 Body Composition The relative amounts of various components in the body, such as percentage of body fat. Body Compositions,Composition, Body,Compositions, Body
D002096 C-Peptide The middle segment of proinsulin that is between the N-terminal B-chain and the C-terminal A-chain. It is a pancreatic peptide of about 31 residues, depending on the species. Upon proteolytic cleavage of proinsulin, equimolar INSULIN and C-peptide are released. C-peptide immunoassay has been used to assess pancreatic beta cell function in diabetic patients with circulating insulin antibodies or exogenous insulin. Half-life of C-peptide is 30 min, almost 8 times that of insulin. Proinsulin C-Peptide,C-Peptide, Proinsulin,Connecting Peptide,C Peptide,C Peptide, Proinsulin,Proinsulin C Peptide
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003652 Decanoic Acids 10-carbon saturated monocarboxylic acids. Capric Acids,Acids, Capric,Acids, Decanoic
D003924 Diabetes Mellitus, Type 2 A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. Diabetes Mellitus, Adult-Onset,Diabetes Mellitus, Ketosis-Resistant,Diabetes Mellitus, Maturity-Onset,Diabetes Mellitus, Non-Insulin-Dependent,Diabetes Mellitus, Slow-Onset,Diabetes Mellitus, Stable,MODY,Maturity-Onset Diabetes Mellitus,NIDDM,Diabetes Mellitus, Non Insulin Dependent,Diabetes Mellitus, Noninsulin Dependent,Diabetes Mellitus, Noninsulin-Dependent,Diabetes Mellitus, Type II,Maturity-Onset Diabetes,Noninsulin-Dependent Diabetes Mellitus,Type 2 Diabetes,Type 2 Diabetes Mellitus,Adult-Onset Diabetes Mellitus,Diabetes Mellitus, Adult Onset,Diabetes Mellitus, Ketosis Resistant,Diabetes Mellitus, Maturity Onset,Diabetes Mellitus, Slow Onset,Diabetes, Maturity-Onset,Diabetes, Type 2,Ketosis-Resistant Diabetes Mellitus,Maturity Onset Diabetes,Maturity Onset Diabetes Mellitus,Non-Insulin-Dependent Diabetes Mellitus,Noninsulin Dependent Diabetes Mellitus,Slow-Onset Diabetes Mellitus,Stable Diabetes Mellitus

Related Publications

Amerigo Iaconelli, and Amalia Gastaldelli, and Chiara Chiellini, and Donatella Gniuli, and Angela Favuzzi, and Christophe Binnert, and Katherine Macé, and Geltrude Mingrone
February 2007, Problemy endokrinologii,
Amerigo Iaconelli, and Amalia Gastaldelli, and Chiara Chiellini, and Donatella Gniuli, and Angela Favuzzi, and Christophe Binnert, and Katherine Macé, and Geltrude Mingrone
August 2007, Problemy endokrinologii,
Amerigo Iaconelli, and Amalia Gastaldelli, and Chiara Chiellini, and Donatella Gniuli, and Angela Favuzzi, and Christophe Binnert, and Katherine Macé, and Geltrude Mingrone
December 2008, Journal of the American College of Nutrition,
Amerigo Iaconelli, and Amalia Gastaldelli, and Chiara Chiellini, and Donatella Gniuli, and Angela Favuzzi, and Christophe Binnert, and Katherine Macé, and Geltrude Mingrone
November 2008, Regulatory peptides,
Amerigo Iaconelli, and Amalia Gastaldelli, and Chiara Chiellini, and Donatella Gniuli, and Angela Favuzzi, and Christophe Binnert, and Katherine Macé, and Geltrude Mingrone
June 2007, The American journal of clinical nutrition,
Amerigo Iaconelli, and Amalia Gastaldelli, and Chiara Chiellini, and Donatella Gniuli, and Angela Favuzzi, and Christophe Binnert, and Katherine Macé, and Geltrude Mingrone
March 2001, The Journal of clinical endocrinology and metabolism,
Amerigo Iaconelli, and Amalia Gastaldelli, and Chiara Chiellini, and Donatella Gniuli, and Angela Favuzzi, and Christophe Binnert, and Katherine Macé, and Geltrude Mingrone
October 2006, Journal of the American College of Nutrition,
Amerigo Iaconelli, and Amalia Gastaldelli, and Chiara Chiellini, and Donatella Gniuli, and Angela Favuzzi, and Christophe Binnert, and Katherine Macé, and Geltrude Mingrone
October 2016, Food & function,
Amerigo Iaconelli, and Amalia Gastaldelli, and Chiara Chiellini, and Donatella Gniuli, and Angela Favuzzi, and Christophe Binnert, and Katherine Macé, and Geltrude Mingrone
April 2014, Journal of the American Medical Directors Association,
Amerigo Iaconelli, and Amalia Gastaldelli, and Chiara Chiellini, and Donatella Gniuli, and Angela Favuzzi, and Christophe Binnert, and Katherine Macé, and Geltrude Mingrone
August 2004, The American journal of clinical nutrition,
Copied contents to your clipboard!